Induced sputum cell profiles in lung transplant recipients with or without chronic rejection: correlation with lung function
Open Access
- 1 July 2001
- Vol. 56 (7) , 557-560
- https://doi.org/10.1136/thorax.56.7.557
Abstract
BACKGROUND Sputum induction is a non-invasive procedure for measuring inflammatory processes of the lower respiratory tract. The aim of this study was to establish sputum cell counts and differentials in patients after lung transplantation (LTx), with or without chronic transplant rejection. METHODS Sputum induction was performed in 41 LTx patients (25 single LTx (sLTx), 16 double LTx (dLTx) and 15 healthy non-smoking volunteers. Sputum was processed according to standard protocols. Total cell count was calculated as mean (SE) cells × 106/ml sputum and cell differential (%) was evaluated after staining. Cellular profiles were correlated with lung function. RESULTS Total sputum cell counts were increased in sLTx (9 (1.9) cells × 106/ml, p=0.01) and dLTx patients (7.2 (1.5) × 106/ml, p=0.01) compared with healthy controls (2.6 (0.6) × 106/ml). There was also a marked sputum neutrophilia in both patient groups (59 (6)% and 62 (6)%, respectively, pv controls). Moreover, in both sLTx and dLTx patients with chronic transplant rejection there was an increased number of sputum neutrophils compared with patients with normal graft function (p1) % predicted): sLTx,r=–0.61, p=0.001; dLTx,r=–0.75, p=0.001, respectively). Sputum lymphocytes and eosinophils were similar in both groups. No relevant side effects occurred during sputum induction. CONCLUSIONS Sputum induction is a safe and non-invasive tool for monitoring lower respiratory tract inflammation in LTx patients. Both sLTx and dLTx patients with chronic rejection had increased sputum neutrophils compared with patients with normal transplant function. These data support findings of other authors highlighting a possible role for neutrophils in the pathogenesis of chronic transplant rejection.Keywords
This publication has 21 references indexed in Scilit:
- Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbationsThorax, 2000
- Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantationThorax, 2000
- Reversal of Human Neutrophil Survival by Leukotriene B4 Receptor Blockade and 5-Lipoxygenase and 5-Lipoxygenase Activating Protein InhibitorsAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Lung transplantation – 10-year experienceEuropean Journal of Cardio-Thoracic Surgery, 1999
- Bronchiolitis Obliterans: Pathogenesis, Prevention, and ManagementThe Lancet Healthy Longevity, 1998
- Effect of diagnosis on survival benefit of lung transplantation for end-stage lung diseaseThe Lancet, 1998
- Mixed (Neutrophil-Rich) Interstitial Pneumonitis in Biopsy Specimens of Lung AllograftsChest, 1998
- Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD.Thorax, 1996
- Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements.American Journal of Respiratory and Critical Care Medicine, 1996
- Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst1Journal of Allergy and Clinical Immunology, 1990